𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cognitive functions affected by scopolamine in alzheimer's disease and normal aging

✍ Scribed by Dr. F. Jacob Huff; Susan F. Mickel; Suzanne Corkin; John H. Growdon


Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
536 KB
Volume
12
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Non-mnestic cognitive function in the sc
✍ Marc C. Obonsawin; Anne Robertson; John R. Crawford; Chris Perera; Shona Walker; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 150 KB πŸ‘ 2 views

The contribution of cholinergic dysfunction to the non-mnestic cognitive impairments associated with senile dementia of the Alzheimer type (SDAT) was investigated. Scopolamine (0 . 5 mg) was administered intravenously to 12 healthy individuals, and their performance on selected subtests of the Wechs

Depression, cognitive impairment and fun
✍ Doree Ann V. Espiritu; Harun Rashid; Benjamin T. Mast; Joe Fitzgerald; Joel Stei πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 61 KB πŸ‘ 2 views

## Abstract Depression is very common in patients with dementia but the relationship is very complex. Depression is regarded as a cause of excess disability in persons with dementia and contributes to their functional decline. The assessment of depression in dementia patients, however, has been dif

Associations between stroke risk and cog
✍ Katherine J. Bangen; Lisa Delano-Wood; Christina E. Wierenga; Ashley McCauley; D πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 165 KB πŸ‘ 1 views

## Abstract ## Background Stroke risk factors have been increasingly implicated in the development of age‐related cognitive decline, the spectrum of vascular cognitive impairment, and, more recently, Alzheimer's disease (AD). In addition, depression and the apolipoprotein (APOE) Ξ΅4 allele have bee